On Monday shares of Fifth Third Bancorp (NASDAQ:FITB) closed at $19.06. Company’s sales growth for last 5 years was -2.90% and EPS growth for next 5 years is recorded as 6.17%. Fifth Third Bancorp (NASDAQ:FITB) cash dividend payment of $0.41406 per share is scheduled to be paid on March 31, 2015. Shareholders who purchased FITBI prior to the ex-dividend date are eligible for the cash dividend payment.
Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) in last trading activity moved down -2.01% to close at $2.44. Company weekly performance is -5.79% while its quarterly performance stands at 39.43%. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) is -30.88% away from its 52 week high. On March 17, Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) announced the induction of Lawrence Mayer, Ph.D., founder, president and chief scientific officer of Celator, to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
On last trading day Prospect Capital Corporation (NASDAQ:PSEC) moved down -0.36% to close at $8.41. Its volatility for the week is 1.12% while volatility for the month is 1.26%. PSEC’s sales growth for past 5 years was 47.90% and its EPS growth for past 5 years was -0.90%. Prospect Capital Corporation (NASDAQ:PSEC) monthly performance is -1.64%. Prospect Capital Corporation (NASDAQ:PSEC) announced that Grier Eliasek, President and Chief Operating Officer, will present live at VirtualInvestorConferences.com on April 2, 2015.
On Monday shares of Bristol-Myers Squibb Company (NYSE:BMY) closed at $65.76. Company’s sales growth for last 5 years was -3.30% and EPS growth for next 5 years is recorded as 16.21%. An Ohio federal judge on Friday dismissed False Claims Act allegations that Bristol-Myers Squibb Company (NYSE:BMY) and Otsuka America Pharmaceutical Inc. defrauded the government and used kickbacks to promote off-label sales of antipsychotic drug Abilify, but left intact whistleblowers’ retaliation claims against BMS.
QUALCOMM, Inc. (NASDAQ:QCOM) in last trading activity increased 2.76% to close at $68.88. Company weekly performance is -1.70% while its quarterly performance stands at -8.38%. QUALCOMM, Inc. (NASDAQ:QCOM) is -14.51% away from its 52 week high. QUALCOMM (NASDAQ:QCOM) was downgraded by research analysts at Vetr from a “strong-buy” rating to a “buy” rating in a report released on Monday. They currently have a $81.28 price objective on the stock. Vetr‘s price objective suggests a potential upside of 18.00% from the stock’s previous close.